Cytodyn Inc (CYDY)

[DonDonDonDon]

" we AIM to have 100,000 doses in 12 months "
this equal to about 33,000 patients , since each need 3 doses..

HGEN released a 10-Q yesterday. It says they spent $51.7 million in manufacturing in the first quarter and will spend at least that much in the second quarter. That is $103.4 million already committed to manufacturing. By my estimates, one lenzilumab treatment costs $100 to manufacture. So that is one million treatments already being made. One million times $10,000 per treatment is $10 billion in sales. And that is just manufacturing paid for in the first half of 2021. Not bad for a company with a market cap of $1 billion.

Also in the 10-Q it said that after having a guidance meeting with the US FDA, HGEN will apply for an EUA by the end of May. The US FDA almost always gives an EUA when they greenlight the application. The US FDA told CytoDyn "thanks, but no thanks" to them applying on both of their trials.